We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$43.1B
AUM Growth
+$2.24B
Cap. Flow
-$849M
Cap. Flow %
-1.97%
Top 10 Hldgs %
11.85%
Holding
2,563
New
364
Increased
1,030
Reduced
917
Closed
227

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$245M
2
META icon
Meta Platforms (Facebook)
META
+$204M
3
EXC icon
Exelon
EXC
+$196M
4
SHW icon
Sherwin-Williams
SHW
+$182M
5
PFE icon
Pfizer
PFE
+$174M

Sector Composition

Rank Sector Weight
1 Technology 16.65%
2 Healthcare 16.47%
3 Consumer Discretionary 15.27%
4 Industrials 11.92%
5 Financials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCI
1851
DELISTED
SRC Energy Inc
SRCI
$538K ﹤0.01%
+130,600
New +$496K
EV
1852
DELISTED
Eaton Vance Corp.
EV
$537K ﹤0.01%
+11,500
New +$532K
BY icon
1853
Byline Bancorp
BY
$1.74B
$536K ﹤0.01%
27,400
-500
-2% -$9.14K
ARCT icon
1854
Arcturus Therapeutics
ARCT
$161M
$533K ﹤0.01%
+49,043
New +$513K
PTC icon
1855
PTC
PTC
$14.3B
$533K ﹤0.01%
7,120
+1,100
+18% +$78.3K
DDD icon
1856
3D Systems Corp
DDD
$425M
$532K ﹤0.01%
+60,845
New +$528K
NKTR icon
1857
Nektar Therapeutics
NKTR
$2.37B
$532K ﹤0.01%
+1,643
New +$476K
MFIC icon
1858
MidCap Financial Investment
MFIC
$794M
$531K ﹤0.01%
30,387
+13,301
+78% +$219K
CTSO icon
1859
Cytosorbents Corp
CTSO
$23.4M
$530K ﹤0.01%
137,700
+31,100
+29% +$136K
CNA icon
1860
CNA Financial
CNA
$14.7B
$529K ﹤0.01%
11,800
-16,200
-58% -$731K
LGTY
1861
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$526K ﹤0.01%
35,325
-6,500
-16% -$102K
CULP icon
1862
Culp Inc
CULP
$46.7M
$523K ﹤0.01%
38,400
+6,300
+20% +$96.7K
JHG
1863
DELISTED
Janus Henderson
JHG
$521K ﹤0.01%
+21,300
New +$508K
OPY icon
1864
Oppenheimer Holdings
OPY
$1.18B
$521K ﹤0.01%
18,970
-21,414
-53% -$597K
SAIA icon
1865
Saia
SAIA
$11B
$521K ﹤0.01%
5,600
-2,400
-30% -$227K
FFWM
1866
DELISTED
First Foundation Inc
FFWM
$517K ﹤0.01%
+29,700
New +$478K
IX icon
1867
ORIX
IX
$44B
$517K ﹤0.01%
31,000
-13,500
-30% -$217K
TG icon
1868
Tredegar Corp
TG
$258M
$516K ﹤0.01%
23,067
-7,300
-24% -$153K
LFCR icon
1869
Lifecore Biomedical
LFCR
$163M
$512K ﹤0.01%
45,258
+3,100
+7% +$33K
SAFM
1870
DELISTED
Sanderson Farms Inc
SAFM
$511K ﹤0.01%
2,900
+960
+49% +$152K
WDR
1871
DELISTED
Waddell & Reed Financial, Inc.
WDR
$508K ﹤0.01%
30,400
-100,800
-77% -$1.64M
SM icon
1872
SM Energy
SM
$7.49B
$507K ﹤0.01%
45,100
-38,600
-46% -$348K
BE icon
1873
Bloom Energy
BE
$51.2B
$506K ﹤0.01%
67,800
-10,600
-14% -$51.4K
RYZ
1874
Ryerson Holding Corp
RYZ
$1.61B
$504K ﹤0.01%
42,635
+16,500
+63% +$163K
FOLD
1875
DELISTED
Amicus Therapeutics
FOLD
$500K ﹤0.01%
+51,376
New +$470K

Similar funds

Two Sigma Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Two Sigma Advisers held 2,563 positions worth $43.1B, up 5.5% from $40.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Two Sigma Advisers's Q4 2019 filing shows 364 new, 1,030 increased, 917 reduced and 227 closed positions. Its largest new stake was Netflix: 5,465,000 shares worth $177M. The largest sale was Microsoft, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Two Sigma Advisers's largest Q4 2019 buy was Netflix: 5,465,000 shares worth $177M.
  • Two Sigma Advisers added most to Merck in Q4 2019, an estimated $245M increase.
  • Two Sigma Advisers's biggest Q4 2019 reduction was Microsoft, cutting an estimated $400M.
  • Two Sigma Advisers fully exited Fidelity National Information Services in Q4 2019, selling an estimated $280M.
  • Two Sigma Advisers's ten largest holdings make up 12% of its $43.1B portfolio in Q4 2019.
  • Two Sigma Advisers opened 364 new positions and closed 227 in Q4 2019.
  • Two Sigma Advisers's portfolio value rose 5.5% quarter-over-quarter to $43.1B.

Based on Two Sigma Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.